Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 969-971, 2006. First published April 13, 2006; 10.1373/clinchem.2006.068023
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.068023v1
52/6/969    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prak, E. T. L.
Right arrow Articles by Nachamkin, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prak, E. T. L.
Right arrow Articles by Nachamkin, I.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Clinical Immunology
Right arrow Pediatric Clinical Chemistry
Right arrow Nutrition
Right arrow Other Areas of Clinical Chemistry
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Current Issues in Laboratory Medicine
Right arrow Cancer Diagnostics (since 2002)
Right arrow Point-of-Care Testing
Right arrow Hemostasis and Thrombosis
Right arrow Infectious Disease
Right arrow Informatics and Statistics
Right arrow Proteomics and Protein Markers
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
Right arrow Drug Monitoring and Toxicology
Right arrow Hematology
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2006;52:969-971.)
© 2006 American Association for Clinical Chemistry, Inc.

Point/Counterpoint

Point: Developing a Curriculum in Clinical Pathology

Eline T. Luning Prak, Jason Park, Gordon Yu and Irving Nachamkina

1 Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.

aAddress correspondence to this author at: University of Pennsylvania School of Medicine, Department of Pathology and Laboratory Medicine, 4th Floor Gates Building, 3400 Spruce St., Philadelphia, PA 19104-4283. Fax 215-662-6655; e-mail nachamki@mail.med.upenn.edu.

The first 20% of the full text of this article appears below.


   Introduction
 
Developing a comprehensive and robust curriculum for residency programs in clinical pathology (CP; 1 also known as laboratory medicine) has been a goal for residency program directors for many years. Although there are many excellent training programs in CP, it is well recognized by faculty and residents that CP training is usually the weakest area of most combined training programs. The proposal by Smith and colleagues on behalf of the Academy of Clinical Laboratory Physicians and Scientists (ACLPS) addresses some of the major reforms needed to upgrade training in Clinical Pathology (1). Although this proposal attempts to be an all-encompassing roadmap to train clinical pathologists in the 21st century, many issues are still apparent that we would like to address here.

The ACLPS proposal is an extensive and detailed document. It is not practical to address the fine details of the proposal; rather, we would like to discuss several issues at the mile-high level. First, what defines a clinical pathologist? The answer to this question provides the foundation for defining residency training goals. Second, what, at a minimum, should be included in the CP residency curriculum? Finally, how should knowledge and technical competence be evaluated as part of a CP residency?


   What Defines a Clinical Pathologist?
 
One can argue whether clinical pathologists are "clinicians, first and foremost" as promoted by the ACLPS proposal. Clearly, one major role for the clinical pathologist is to serve as a consultant to physicians and other healthcare providers in other medical specialties. Of course, a clinical pathologist should have considerable knowledge of medicine, but in our view, the primary expertise and focus of CP residency training should be on clinical laboratory testing and its integration into the practice of medicine. Clinical pathologists . . . [Full Text of this Article]


   Minimum Requirements for the Curriculum
 

   Evaluation of Competency
 



The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
M. G. Scott and D. E. Bruns
Improving training in laboratory medicine.
Clin. Chem., June 1, 2006; 52(6): 915 - 916.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.